Almawave among the first companies in Europe to certify the use of AI in medical device area | Almawave
x icon pop up DISCOVER MORE

Search the site

Didn't find what you were looking for?

Screenshot 2024-02-12 162320

12 February 2024

Almawave among the first companies in Europe to certify the use of AI in medical device area

Almawave, an Italian company listed on the Euronext Growth Milan market (Ticker: AIW), a Data & Artificial Intelligence player, part of the Almaviva Group, further strengthens its positioning in the healthcare field, obtaining prestigious certifications for the use of Artificial Intelligence in this sensitive sector that requires strict compliance with the authorities’ standards.

On the strength of this initial objective, Almawave plans to extend the MDR certification process also to other AI application cases.

Almawave is therefore one of the first companies in Europe to have MDR certification issued by a Notified Body. This important certificate is related to “DevAIce”, an AI application-based Medical Device solution developed in-house by the Almawave team and successfully validated in an operative clinical trial.

“I am very happy that Almawave has achieved these important certifications. Artificial intelligence will certainly be able to support not only the efficiency of healthcare, but also of improving people’s quality of life, commented Valeria Sandei, CEO of Almawave. “What is important is that the adoption of potential new technologies in the telemedicine area is always accompanied by strict criteria focused on protecting people. MDR certification, particularly on innovative issues such as those we deal with, is a long and complex journey, but one focused on ascertaining technical and clinical aspects of primary importance.”

Download press release arrow right